Cardiology
|
August 21, 2024

Berberine and Losartan: Understanding Drug Interactions and Benefits

Medically Reviewed by
Updated On
September 17, 2024

Natural products can be equally dangerous as they can be advantageous when combined with the wrong substances. Berberine, a potent bioactive compound found in many herbs, offers numerous health benefits but should be used cautiously with other medications, including losartan, a drug used to treat high blood pressure (hypertension) and heart failure.

Understanding the interaction between berberine and losartan is crucial for practitioners and patients. This article explores how this combination can impact blood pressure management and the effectiveness of treatment protocols.

[signup]

Understanding Berberine

Berberine is an isoquinoline alkaloid derived from the stems, roots, and bark of plants such as tree turmeric, barberry, yellowroot, and California poppy (15,19). It has been used for its medicinal properties in Chinese and Ayurvedic medicine for thousands of years.Β 

Berberine has a bitter taste and is known for its vibrant yellow color, which made it historically valuable as a dye for wool, leather, and wood and for its fluorescent properties in laboratory settings. (4,19)

Benefits and MechanismsΒ 

Isoquinoline alkaloids, including berberine, are excellent pharmacological mediators, although their potency and activities vary depending on their unique structures. Berberine offers several health benefits; however, the underlying mechanisms are still under investigation.

Inflammation

Berberine's medicinal properties largely stem from its potent anti-inflammatory and antioxidant activities. It reduces the release of inflammatory cytokines, reactive oxygen species (ROS), and other inflammatory mediators while promoting anti-inflammatory cytokines. (37,43,59)Β 

Studies have shown that berberine can block inflammatory pathways, including NF-ΞΊB and MAPK, possibly by activating AMPK.

Antimicrobial

Berberine is an antimicrobial agent with a broad spectrum of activity against various pathogens, including bacteria, fungi, protozoa, and viruses.Β 

Its mechanism of action involves targeting bacterial cell walls and membranes, leading to increased permeability and cell death. (34)Β 

In fungi, berberine disrupts cell membrane integrity and inhibits the synthesis of ergosterol, a cheif component of the fungal cell membrane. (50)Β 

For protozoa, it interferes with metabolism and replication, while in viruses, it impedes viral entry into host cells and inhibits replication. (24,47)

Diabetes

Berberine can reduce blood glucose levels, HbA1c, and cholesterol and improve insulin sensitivity. (56) This is partly due to AMPK activation, which promotes glucose uptake and insulin sensitivity, and partly due to its anti-inflammatory and antioxidant effects. (19,32)

Berberine can inhibit glucose production in the liver, helping lower blood sugar levels. Additionally, many studies have shown berberine can alter the gut microbiome, affecting glucose metabolism and insulin sensitivity.(14,42,56)

CNS Disorders

Berberine can penetrate the blood-brain barrier (BBB), allowing it to exert its pharmacological effects in the central nervous system (CNS). By reducing brain inflammation and oxidation and promoting cell growth and survival, berberine can reduce depression and anxiety symptoms as well as act as a neuroprotectant in degenerative diseases, such as Alzheimer's. (17,36,51)

Studies have supported the use of berberine in Alzheimer's and Parkinson's disease, mainly due to its anti-inflammatory effects (9,28,35,46). Similar to other antidepressants, berberine modulates neurotransmitter levels by inhibiting monoamine oxidase (MAO), a protein that breaks down neurotransmitters.Β 

Cancer

Berberine's pharmacological effects can differ significantly between normal cells and cancer cells. In cancer cells, berberine can inhibit proliferation and metastasis and promote cell death in breast, lung, prostate, and colon cancers.(29,30,40,43)Β 

In hypoxic environments (areas of low oxygen, such as tumors), berberine can inhibit cancer growth and metastasis and improve survival rates.

GastrointestinalΒ 

Berberine's gastrointestinal and antidiarrheal effects have been well-documented for thousands of years. By reducing inflammation in the gut, berberine can alleviate diarrheal symptoms and restore gut health by fostering the growth of beneficial bacteria and reducing the bad. (20,53)

Berberine can affect gastrointestinal motility, helping to normalize bowel movements. However, high doses or prolonged use of berberine can also lead to gastrointestinal events. (22) Nonetheless, berberine has been suggested as a treatment for ulcerative colitis. (23,59)

Women's Health

Berberine is a promising therapeutic for managing polycystic ovarian syndrome (PCOS). In addition to improving insulin sensitivity, a common issue with PCOS, berberine can lower androgen levels, helping to alleviate hirsutism and acne caused by hyperandrogenism. (54)

Furthermore, berberine can help regulate menstrual cycles and improve ovulation rates, thereby enhancing fertility outcomes, particularly for women with PCOS.Β 

Liver Protection

Berberine exerts hepatoprotective effects by reducing oxidative stress, protecting liver cells from injury and apoptosis. (58)Β 

Berberine's potent anti-inflammatory properties are crucial in protecting from liver damage caused by chronic inflammation. Berberine activates AMPK, leading to decreased lipid accumulation in liver cells, regulating lipid metabolism, and reducing the risk of steatosis and subsequent liver damage.

Side Effects of Berberine

Berberine is generally considered safe for most; however, it can cause side effects, specifically when taken in high doses or for extended periods.Β 

  • Gastrointestinal Events: The most common side effects reported include diarrhea, constipation, abdominal pain, flatulence, nausea, and vomiting. (22)
  • Low Blood Sugar: While this can be beneficial for those with diabetes, berberine can cause hypoglycemia in others. (33)
  • Liver and Kidney Toxicity: High doses and prolonged usage of berberine are associated with liver and kidney toxicity. (38)

Metabolism of Berberine

Berberine has poor bioavailability, and research is underway to optimize delivery through nanoparticles and phytosomes. (16,34)Β 

Berberine is typically pumped out of cells by P-glycoprotein, a drug efflux pump. Some studies have suggested that berberine can also inhibit P-glycoprotein, which could enhance the absorption and bioavailability of other drugs(57); however, this is highly debated.(16,34,55)Β 

In the liver, berberine is capable of inhibiting CYP450, a very abundant metabolic enzyme.(18)

Supplement Forms and Dosages

The FDA does not regulate Berberine, so users should consult with healthcare providers to ensure they purchase a high-quality supplement. Due to berberine's short half-life, spreading dosages out 2-3x per day before meals are recommended, with a total daily dose of 1.5 g. It is generally advised to start with a lower dose and gradually increase.Β 

Berberine Drug Interactions

Because of berberine's diverse set of mechanisms, it is crucial to consider potential drug interactions and consult with a trusted healthcare provider before incorporating berberine.

  • Drugs metabolized by CYP450: CYP450 is an abundant enzyme in the liver responsible for metabolizing many medications. Berberine inhibition can increase blood levels of drugs metabolized by these enzymes, leading to adverse effects and reduced or enhanced efficacy.Β 
  • Hyperglycemic Agents: Berberine can lower blood sugar levels. When combined with insulin or other medications for diabetes, such as metformin or sulfonylureas, it may enhance their effects, potentially leading to hypoglycemia. (31)
  • Immunosuppressants: Berberine can decrease the rate of metabolism and excretion of immunosuppressants, such as cyclosporine and tacrolimus, leading to enhanced and prolonged drug effects and side effects. Cyclosporine and berberine are considered a significant drug interaction and should not be taken together.
  • Sedative Medications: Combining berberine and sedative medications, such as midazolam and pentobarbital, may cause excessive sleepiness.Β 
  • Anticoagulants: Studies have shown that berberine can inhibit thrombin, a key enzyme in blood coagulation. Taking berberine with other anticoagulants can slow blood clotting further and increase the risk of bruising or bleeding. (45)

Understanding Losartan

Losartan is an antihypertensive medication that blocks the action of angiotensin II, a hormone that narrows blood vessels and increases blood pressure. By relaxing blood vessels, losartan lowers blood pressure and improves blood flow, reducing the workload on the heart and making it a suitable treatment for hypertension and heart failure.Β 

Additionally, losartan can protect kidneys from damage in people with type 2 diabetes by reducing proteinuria (protein in the urine), an indicator of kidney damage.Β 

Side Effects of Losartan

Common side effects of losartan include:Β 

  • Dizziness and tirednessΒ 
  • Low blood pressure (hypotension): Excessively low blood pressure suggests dosages may need to be altered.
  • High blood potassium levelsΒ 

Metabolism of Losartan

Losartan is a prodrug, meaning it is metabolically activated in the liver, specifically by the enzyme CYP450.Β 

Losartan Drug Interactions

  • NSAIDs: Both losartan and NSAIDs can affect the kidneys, increasing the risk of kidney issues. Additionally, NSAIDs can increase blood pressure, which would weaken the effects of losartan.Β Β 
  • Lithium: Losartan can decrease the renal clearance of lithium, which can lead to an accumulation of lithium in the body, causing lithium toxicity.
  • Antibiotics: Rifampin can increase the rate at which the body eliminates losartan, weakening its effect by inhibiting its metabolic activation. (49) As a CYP450 inhibitor, clarithromycin can interact with losartan by lowering its metabolic activation.
  • Antifungals: Fluconazole, ketoconazole, and itraconazole are CYP450 inhibitors, weakening the effect of losartan by inhibiting its metabolic activation.
  • Blood Pressure Medications: Combining losartan with potassium-sparing diuretics (e.g., spironolactone) can cause high potassium levels (hyperkalemia), potentially leading to kidney issues. (52)

Berberine and Losartan

When combining natural supplements with prescription medications, it's crucial to be aware of potential interactions that could influence the effectiveness and safety of your treatment regimen. This is particularly true for the combination of berberine and losartan, where careful consideration is needed.

Potential Interactions

Taking berberine and losartan together may decrease losartan's efficacy. Because berberine inhibits CYP450 enzymes, it could slow down the metabolism and activation of losartan.Β 

A 2016 study found that berberine increased plasma levels of inactive losartan by decreasing its metabolism into its active metabolite in rats, thus reducing its effects. The net effect of berberine on losartan may depend on the balance between these interactions.Β 

If the inhibition of CYP450 significantly reduces the conversion of losartan to its active metabolite, the antihypertensive effect of losartan could be decreased. (27)

On the contrary, losartan is a substrate of P-glycoprotein, and because some evidence has suspected berberine can inhibit P-glycoprotein, this could cause enhanced absorption and efficacy of losartan; however, less data is supporting this and is under debate. (27)

Benefits and Precautions

Losartan and berberine are often used together to treat senile diabetic nephropathy, as the combination can provide better control of blood pressure and blood sugar levels. However, when used together, their dual effect on hypertension can lead to additive effects, which might result in excessively low blood pressure.Β 

This concern extends to combining berberine with other hypertension agents as well. This is especially important for individuals already taking medications to lower blood pressure or those prone to low blood pressure. (27)

For individuals seeking to take berberine and losartan, healthcare providers should closely monitor blood pressure, blood sugar, potassium levels, and kidney and liver function. Dosage adjustments of either medication may also be necessary to individualize treatment plans, optimize therapeutic outcomes, and minimize risks.

[signup]

Key Takeaways

  • The interaction between berberine and losartan is complex, largely because berberine inhibits CYP450 enzymes, potentially reducing losartan’s effectiveness.
  • While combining berberine and losartan can provide improved management of conditions like senile diabetic nephropathy, risks include excessively low blood pressure and potential adverse effects on the kidney and liver.
  • Patients should consult their healthcare providers before combining berberine with losartan to ensure safe and effective treatment.
  • Tailoring dosages and closely monitoring blood pressure, blood sugar, and organ function are essential for optimizing therapeutic outcomes and minimizing risks.

Natural products can have both positive and negative effects, especially when combined with other substances. Berberine, a compound found in many herbs, may offer health benefits but should be used carefully with other medications, including losartan, a drug used to help manage high blood pressure (hypertension) and heart failure.

Understanding the interaction between berberine and losartan is important for healthcare providers and patients. This article explores how this combination might influence blood pressure management and the effectiveness of treatment plans.

[signup]

Understanding Berberine

Berberine is an isoquinoline alkaloid derived from the stems, roots, and bark of plants such as tree turmeric, barberry, yellowroot, and California poppy (15,19). It has been used in traditional Chinese and Ayurvedic medicine for thousands of years.Β 

Berberine has a bitter taste and is known for its vibrant yellow color, which made it historically valuable as a dye for wool, leather, and wood and for its fluorescent properties in laboratory settings. (4,19)

Benefits and MechanismsΒ 

Isoquinoline alkaloids, including berberine, are known for their pharmacological properties, although their potency and activities vary depending on their unique structures. Berberine may offer several health benefits; however, the underlying mechanisms are still being studied.

Inflammation

Berberine's properties are thought to stem from its anti-inflammatory and antioxidant activities. It may help reduce the release of inflammatory cytokines, reactive oxygen species (ROS), and other inflammatory mediators while promoting anti-inflammatory cytokines. (37,43,59)Β 

Studies suggest that berberine may influence inflammatory pathways, including NF-ΞΊB and MAPK, possibly by activating AMPK.

Antimicrobial

Berberine is known for its antimicrobial properties, which may affect various pathogens, including bacteria, fungi, protozoa, and viruses.Β 

Its mechanism of action is thought to involve targeting bacterial cell walls and membranes, potentially leading to increased permeability. (34)Β 

In fungi, berberine may disrupt cell membrane integrity and inhibit the synthesis of ergosterol, a chief component of the fungal cell membrane. (50)Β 

For protozoa, it might interfere with metabolism and replication, while in viruses, it could impede viral entry into host cells and inhibit replication. (24,47)

Diabetes

Berberine may help support healthy blood glucose levels, HbA1c, and cholesterol and improve insulin sensitivity. (56) This is partly due to AMPK activation, which may promote glucose uptake and insulin sensitivity, and partly due to its anti-inflammatory and antioxidant effects. (19,32)

Berberine might inhibit glucose production in the liver, which could help support healthy blood sugar levels. Additionally, many studies have shown berberine may alter the gut microbiome, affecting glucose metabolism and insulin sensitivity.(14,42,56)

CNS Disorders

Berberine can penetrate the blood-brain barrier (BBB), allowing it to exert its effects in the central nervous system (CNS). By potentially reducing brain inflammation and oxidation and promoting cell growth and survival, berberine may help support mental well-being and act as a neuroprotectant in degenerative diseases, such as Alzheimer's. (17,36,51)

Studies have supported the use of berberine in Alzheimer's and Parkinson's disease, mainly due to its anti-inflammatory effects (9,28,35,46). Similar to other antidepressants, berberine may modulate neurotransmitter levels by inhibiting monoamine oxidase (MAO), a protein that breaks down neurotransmitters.Β 

Cancer

Berberine's effects can differ significantly between normal cells and cancer cells. In cancer cells, berberine may inhibit proliferation and metastasis and promote cell death in breast, lung, prostate, and colon cancers.(29,30,40,43)Β 

In low oxygen environments (such as tumors), berberine may inhibit cancer growth and metastasis and improve survival rates.

GastrointestinalΒ 

Berberine's gastrointestinal effects have been noted for thousands of years. By potentially reducing inflammation in the gut, berberine may help support gut health by fostering the growth of beneficial bacteria. (20,53)

Berberine may affect gastrointestinal motility, helping to support normal bowel movements. However, high doses or prolonged use of berberine can also lead to gastrointestinal events. (22) Nonetheless, berberine has been suggested as a supportive tool for managing ulcerative colitis. (23,59)

Women's Health

Berberine is a promising option for supporting the management of polycystic ovarian syndrome (PCOS). In addition to potentially improving insulin sensitivity, a common issue with PCOS, berberine may help support balanced androgen levels, which could help with hirsutism and acne. (54)

Furthermore, berberine may help support regular menstrual cycles and improve ovulation rates, thereby enhancing fertility outcomes, particularly for women with PCOS.Β 

Liver Protection

Berberine may exert hepatoprotective effects by reducing oxidative stress, potentially protecting liver cells from injury. (58)Β 

Berberine's anti-inflammatory properties are thought to be crucial in protecting from liver damage caused by chronic inflammation. Berberine may activate AMPK, leading to decreased lipid accumulation in liver cells, which could help regulate lipid metabolism and reduce the risk of liver issues.

Side Effects of Berberine

Berberine is generally considered safe for most; however, it can cause side effects, specifically when taken in high doses or for extended periods.Β 

  • Gastrointestinal Events: The most common side effects reported include diarrhea, constipation, abdominal pain, flatulence, nausea, and vomiting. (22)
  • Low Blood Sugar: While this can be beneficial for those with diabetes, berberine can cause hypoglycemia in others. (33)
  • Liver and Kidney Toxicity: High doses and prolonged usage of berberine are associated with liver and kidney toxicity. (38)

Metabolism of Berberine

Berberine has poor bioavailability, and research is underway to optimize delivery through nanoparticles and phytosomes. (16,34)Β 

Berberine is typically pumped out of cells by P-glycoprotein, a drug efflux pump. Some studies have suggested that berberine can also inhibit P-glycoprotein, which could enhance the absorption and bioavailability of other drugs(57); however, this is highly debated.(16,34,55)Β 

In the liver, berberine is capable of inhibiting CYP450, a very abundant metabolic enzyme.(18)

Supplement Forms and Dosages

The FDA does not regulate Berberine, so users should consult with healthcare providers to ensure they purchase a high-quality supplement. Due to berberine's short half-life, spreading dosages out 2-3x per day before meals is often suggested, with a total daily dose of 1.5 g. It is generally advised to start with a lower dose and gradually increase.Β 

Berberine Drug Interactions

Because of berberine's diverse set of mechanisms, it is crucial to consider potential drug interactions and consult with a trusted healthcare provider before incorporating berberine.

  • Drugs metabolized by CYP450: CYP450 is an abundant enzyme in the liver responsible for metabolizing many medications. Berberine inhibition can increase blood levels of drugs metabolized by these enzymes, leading to adverse effects and reduced or enhanced efficacy.Β 
  • Hyperglycemic Agents: Berberine can lower blood sugar levels. When combined with insulin or other medications for diabetes, such as metformin or sulfonylureas, it may enhance their effects, potentially leading to hypoglycemia. (31)
  • Immunosuppressants: Berberine can decrease the rate of metabolism and excretion of immunosuppressants, such as cyclosporine and tacrolimus, leading to enhanced and prolonged drug effects and side effects. Cyclosporine and berberine are considered a significant drug interaction and should not be taken together.
  • Sedative Medications: Combining berberine and sedative medications, such as midazolam and pentobarbital, may cause excessive sleepiness.Β 
  • Anticoagulants: Studies have shown that berberine can inhibit thrombin, a key enzyme in blood coagulation. Taking berberine with other anticoagulants can slow blood clotting further and increase the risk of bruising or bleeding. (45)

Understanding Losartan

Losartan is an antihypertensive medication that blocks the action of angiotensin II, a hormone that narrows blood vessels and increases blood pressure. By relaxing blood vessels, losartan helps lower blood pressure and improve blood flow, reducing the workload on the heart and making it a suitable option for managing hypertension and heart failure.Β 

Additionally, losartan may help protect kidneys from damage in people with type 2 diabetes by reducing proteinuria (protein in the urine), an indicator of kidney damage.Β 

Side Effects of Losartan

Common side effects of losartan include:Β 

  • Dizziness and tirednessΒ 
  • Low blood pressure (hypotension): Excessively low blood pressure suggests dosages may need to be altered.
  • High blood potassium levelsΒ 

Metabolism of Losartan

Losartan is a prodrug, meaning it is metabolically activated in the liver, specifically by the enzyme CYP450.Β 

Losartan Drug Interactions

  • NSAIDs: Both losartan and NSAIDs can affect the kidneys, increasing the risk of kidney issues. Additionally, NSAIDs can increase blood pressure, which would weaken the effects of losartan.Β Β 
  • Lithium: Losartan can decrease the renal clearance of lithium, which can lead to an accumulation of lithium in the body, causing lithium toxicity.
  • Antibiotics: Rifampin can increase the rate at which the body eliminates losartan, weakening its effect by inhibiting its metabolic activation. (49) As a CYP450 inhibitor, clarithromycin can interact with losartan by lowering its metabolic activation.
  • Antifungals: Fluconazole, ketoconazole, and itraconazole are CYP450 inhibitors, weakening the effect of losartan by inhibiting its metabolic activation.
  • Blood Pressure Medications: Combining losartan with potassium-sparing diuretics (e.g., spironolactone) can cause high potassium levels (hyperkalemia), potentially leading to kidney issues. (52)

Berberine and Losartan

When combining natural supplements with prescription medications, it's crucial to be aware of potential interactions that could influence the effectiveness and safety of your treatment regimen. This is particularly true for the combination of berberine and losartan, where careful consideration is needed.

Potential Interactions

Taking berberine and losartan together may decrease losartan's efficacy. Because berberine inhibits CYP450 enzymes, it could slow down the metabolism and activation of losartan.Β 

A 2016 study found that berberine increased plasma levels of inactive losartan by decreasing its metabolism into its active metabolite in rats, thus reducing its effects. The net effect of berberine on losartan may depend on the balance between these interactions.Β 

If the inhibition of CYP450 significantly reduces the conversion of losartan to its active metabolite, the antihypertensive effect of losartan could be decreased. (27)

On the contrary, losartan is a substrate of P-glycoprotein, and because some evidence has suspected berberine can inhibit P-glycoprotein, this could cause enhanced absorption and efficacy of losartan; however, less data is supporting this and is under debate. (27)

Benefits and Precautions

Losartan and berberine are sometimes used together to help manage senile diabetic nephropathy, as the combination may provide better control of blood pressure and blood sugar levels. However, when used together, their dual effect on hypertension can lead to additive effects, which might result in excessively low blood pressure.Β 

This concern extends to combining berberine with other hypertension agents as well. This is especially important for individuals already taking medications to lower blood pressure or those prone to low blood pressure. (27)

For individuals considering taking berberine and losartan, healthcare providers should closely monitor blood pressure, blood sugar, potassium levels, and kidney and liver function. Dosage adjustments of either medication may also be necessary to individualize treatment plans, optimize therapeutic outcomes, and minimize risks.

[signup]

Key Takeaways

  • The interaction between berberine and losartan is complex, largely because berberine inhibits CYP450 enzymes, potentially reducing losartan’s effectiveness.
  • While combining berberine and losartan may help manage conditions like senile diabetic nephropathy, risks include excessively low blood pressure and potential adverse effects on the kidney and liver.
  • Patients should consult their healthcare providers before combining berberine with losartan to ensure safe and effective treatment.
  • Tailoring dosages and closely monitoring blood pressure, blood sugar, and organ function are essential for optimizing therapeutic outcomes and minimizing risks.
The information in this article is designed for educational purposes only and is not intended to be a substitute for informed medical advice or care. This information should not be used to diagnose or treat any health problems or illnesses without consulting a doctor. Consult with a health care practitioner before relying on any information in this article or on this website.

Learn more

No items found.

Lab Tests in This Article

No lab tests!
  1. Berberine. Retrieved from https://medlineplus.gov/druginfo/natural/1126.html
  2. Losartan (Oral Route). Retrieved from https://www.mayoclinic.org/drugs-supplements/losartan-oral-route/description/drg-20067341
  3. What To Know About Berberine: Benefits, Uses and Side Effects. (2023). Retrieved from https://health.clevelandclinic.org/berberine-for-insulin-resistance-weight-loss
  4. Berlin GE, L. (1983). Fluorescent Berberine Binding as a Marker of Secretory Activity in Mast Cells. Int. Arch. Allergy Appl. Immunol., 71, 332-339.Β  https://pubmed.ncbi.nlm.nih.gov/6190761/
  5. Bertagna B. (2024). The Role of Berberine in Restoring Hormonal Balance in PCOS. Rupa Health. Retrieved from https://www.rupahealth.com/post/the-role-of-berberine-in-restoring-hormonal-balance-in-pcos
  6. Blake K. (2023). Integrative Strategies for Neurodegenerative Disease Management. Rupa Health. Retrieved from https://www.rupahealth.com/post/integrative-strategies-for-neurodegenerative-disease-management
  7. Blanche PR, E.; Kerob, D.; Galezowski, N. (1997). Lithium intoxication in an elderly patient after combined treatment with losartan. Eur J Clin Pharmacol, 52.Β  https://pubmed.ncbi.nlm.nih.gov/9342587/
  8. Blevins H. (2024). The Blood-Brain Barrier and its Role in Neurodegenerative Diseases. Rupa Health. Retrieved from https://www.rupahealth.com/post/the-blood-brain-barrier-and-its-role-in-neurodegenerative-diseases
  9. Cheng Z, Kang C, Che S, et al. (2022). Berberine: A Promising Treatment for Neurodegenerative Diseases. Front Pharmacol, 13, 845591. doi:10.3389/fphar.2022.845591 https://www.ncbi.nlm.nih.gov/pubmed/35668943
  10. Cloyd J. (2023). A Root Cause Medicine Approach to Treating Hypotension. Rupa Health. Retrieved from https://www.rupahealth.com/post/integrative-medicine-approach-to-treating-hypotension
  11. Cloyd J. (2024). Testing Your Patient's Hemogloblin A1c Levels: A Crucial Tool for Diabetes Management. Rupa Health. Retrieved from https://www.rupahealth.com/post/hba1c-testing-a-crucial-tool-for-diabetes-management-in-functional-medicine
  12. Cloyd J. (2024). What is the Gut Microbiome? Rupa Health. Retrieved from https://www.rupahealth.com/post/what-is-the-gut-microbiome
  13. Cloyd K. (2023). Interpreting Oxidative Stress Markers. Rupa Health. Retrieved from https://www.rupahealth.com/post/interpreting-oxidative-stress-markers
  14. Cui HX, Hu YN, Li JW,Yuan K. (2018). Hypoglycemic Mechanism of the Berberine Organic Acid Salt under the Synergistic Effect of Intestinal Flora and Oxidative Stress. Oxid Med Cell Longev, 2018, 8930374. doi:10.1155/2018/8930374 https://www.ncbi.nlm.nih.gov/pubmed/30662584
  15. Daglis S. (2024). Berberine 101: What It Is, Benefits, and Side Effects. Rupa Health. Retrieved from https://www.rupahealth.com/post/berberine-101-what-it-is-benefits-and-side-effects
  16. Di Pierro F, Sultana R, Eusaph AZ, et al. (2023). Effect of Berberine Phytosome on reproductive, dermatologic, and metabolic characteristics in women with polycystic ovary syndrome: a controlled, randomized, multi-centric, open-label clinical trial. Front Pharmacol, 14, 1269605. doi:10.3389/fphar.2023.1269605 https://www.ncbi.nlm.nih.gov/pubmed/38074133
  17. Fan J, Zhang K, Jin Y, et al. (2019). Pharmacological effects of berberine on mood disorders. J Cell Mol Med, 23(1), 21-28. doi:10.1111/jcmm.13930 https://www.ncbi.nlm.nih.gov/pubmed/30450823
  18. Guo Y, Pope C, Cheng X, Zhou H,Klaassen CD. (2011). Dose-response of berberine on hepatic cytochromes P450 mRNA expression and activities in mice. J Ethnopharmacol, 138(1), 111-8. doi:10.1016/j.jep.2011.08.058 https://www.ncbi.nlm.nih.gov/pubmed/21920422
  19. Gupta SCP, S.; Aggarwal, B. B. (Ed.) (2016). Anti-inflammatory Nutraceuticals and Chronic Diseases: Springer International Publishing. https://link.springer.com/book/10.1007/978-3-319-41334-1
  20. Habtemariam S. (2020). Berberine pharmacology and the gut microbiota: A hidden therapeutic link. Pharmacol Res, 155, 104722. doi:10.1016/j.phrs.2020.104722 https://www.ncbi.nlm.nih.gov/pubmed/32105754
  21. Han Y, Guo S, Li Y, et al. (2023). Berberine ameliorate inflammation and apoptosis via modulating PI3K/AKT/NFkappaB and MAPK pathway on dry eye. Phytomedicine, 121, 155081. doi:10.1016/j.phymed.2023.155081 https://www.ncbi.nlm.nih.gov/pubmed/37748390
  22. Harrison SA, Gunn N, Neff GW, et al. (2021). A phase 2, proof of concept, randomised controlled trial of berberine ursodeoxycholate in patients with presumed non-alcoholic steatohepatitis and type 2 diabetes. Nat Commun, 12(1), 5503. doi:10.1038/s41467-021-25701-5 https://www.ncbi.nlm.nih.gov/pubmed/34535644
  23. Jing W, Dong S, Luo X, et al. (2021). Berberine improves colitis by triggering AhR activation by microbial tryptophan catabolites. Pharmacol Res, 164, 105358. doi:10.1016/j.phrs.2020.105358 https://www.ncbi.nlm.nih.gov/pubmed/33285228
  24. Kaneda Y, Tanaka T,Saw T. (1990). Effects of berberine, a plant alkaloid, on the growth of anaerobic protozoa in axenic culture. Tokai J Exp Clin Med, 15(6), 417-23.Β  https://www.ncbi.nlm.nih.gov/pubmed/2131648
  25. Kaukonen K-MO, K. T.; Neuvonen, P. J. . (1998). Fluconazole but not itraconazole decreases the metabolism of losartan to E-3174. Eur J Clin Pharmacol, 53, 445-449.Β Β 
  26. Kulkarni SK,Dhir A. (2008). On the mechanism of antidepressant-like action of berberine chloride. Eur J Pharmacol, 589(1-3), 163-72. doi:10.1016/j.ejphar.2008.05.043 https://www.ncbi.nlm.nih.gov/pubmed/18585703
  27. Li H, Liu L, Xie L, Gan D, Jiang X. (2016). Effects of berberine on the pharmacokinetics of losartan and its metabolite EXP3174 in rats and its mechanism. Pharm Biol, 54(12), 2886-2894. doi:10.1080/13880209.2016.1190762 https://www.ncbi.nlm.nih.gov/pubmed/27327872
  28. Li X, Chen J, Feng W, et al. (2023). Berberine ameliorates iron levels and ferroptosis in the brain of 3 x Tg-AD mice. Phytomedicine, 118, 154962. doi:10.1016/j.phymed.2023.154962 https://www.ncbi.nlm.nih.gov/pubmed/37506403
  29. Liu Q, Tang J, Chen S, et al. (2022). Berberine for gastric cancer prevention and treatment: Multi-step actions on the Correa's cascade underlie its therapeutic effects. Pharmacol Res, 184, 106440. doi:10.1016/j.phrs.2022.106440 https://www.ncbi.nlm.nih.gov/pubmed/36108874
  30. Liu Y, Liu X, Zhang N, et al. (2020). Berberine diminishes cancer cell PD-L1 expression and facilitates antitumor immunity via inhibiting the deubiquitination activity of CSN5. Acta Pharm Sin B, 10(12), 2299-2312. doi:10.1016/j.apsb.2020.06.014 https://www.ncbi.nlm.nih.gov/pubmed/33354502
  31. Lyu Y, Li D, Yuan X, et al. (2022). Effects of combination treatment with metformin and berberine on hypoglycemic activity and gut microbiota modulation in db/db mice. Phytomedicine, 101, 154099. doi:10.1016/j.phymed.2022.154099 https://www.ncbi.nlm.nih.gov/pubmed/35489323
  32. Ma X, Chen Z, Wang L, et al. (2018). The Pathogenesis of Diabetes Mellitus by Oxidative Stress and Inflammation: Its Inhibition by Berberine. Front Pharmacol, 9, 782. doi:10.3389/fphar.2018.00782 https://www.ncbi.nlm.nih.gov/pubmed/30100874
  33. Ming J, Yu X, Xu X, et al. (2021). Effectiveness and safety of Bifidobacterium and berberine in human hyperglycemia and their regulatory effect on the gut microbiota: a multi-center, double-blind, randomized, parallel-controlled study. Genome Med, 13(1), 125. doi:10.1186/s13073-021-00942-7 https://www.ncbi.nlm.nih.gov/pubmed/34365978
  34. Nguyen HT, Pham TN, Le AT, Thuy NT, Huy TQ,Nguyen TTT. (2022). Antibacterial activity of a berberine nanoformulation. Beilstein J Nanotechnol, 13, 641-652. doi:10.3762/bjnano.13.56 https://www.ncbi.nlm.nih.gov/pubmed/35923171
  35. Qin S, Tang H, Li W, et al. (2020). AMPK and its Activator Berberine in the Treatment of Neurodegenerative Diseases. Curr Pharm Des, 26(39), 5054-5066. doi:10.2174/1381612826666200523172334 https://www.ncbi.nlm.nih.gov/pubmed/32445451
  36. Qin Z, Shi DD, Li W, et al. (2023). Berberine ameliorates depression-like behaviors in mice via inhibiting NLRP3 inflammasome-mediated neuroinflammation and preventing neuroplasticity disruption. J Neuroinflammation, 20(1), 54. doi:10.1186/s12974-023-02744-7 https://www.ncbi.nlm.nih.gov/pubmed/36859349
  37. Shakeri F, Kiani S, Rahimi G, Boskabady MH. (2024). Anti-inflammatory, antioxidant, and immunomodulatory effects of Berberis vulgaris and its constituent berberine, experimental and clinical, a review. Phytother Res, 38(4), 1882-1902. doi:10.1002/ptr.8077 https://www.ncbi.nlm.nih.gov/pubmed/38358731
  38. Singh N, Sharma B. (2018). Toxicological Effects of Berberine and Sanguinarine. Front Mol Biosci, 5, 21. doi:10.3389/fmolb.2018.00021 https://www.ncbi.nlm.nih.gov/pubmed/29616225
  39. Stanford J. (2024). Berberine & Its Effect On Insulin Resistance. Rupa Health. Retrieved from https://www.rupahealth.com/post/berberine-its-effect-on-insulin-resistance
  40. Sun Y, Zhou Q, Chen F, et al. (2023). Berberine inhibits breast carcinoma proliferation and metastasis under hypoxic microenvironment involving gut microbiota and endogenous metabolites. Pharmacol Res, 193, 106817. doi:10.1016/j.phrs.2023.106817 https://www.ncbi.nlm.nih.gov/pubmed/37315824
  41. Teeter LA. (2023). What is Ayurvedic Medicine? Rupa Health. Retrieved from https://www.rupahealth.com/post/what-is-ayurvedic-medicine
  42. Tian Y, Cai J, Gui W, et al. (2019). Berberine Directly Affects the Gut Microbiota to Promote Intestinal Farnesoid X Receptor Activation. Drug Metab Dispos, 47(2), 86-93. doi:10.1124/dmd.118.083691 https://www.ncbi.nlm.nih.gov/pubmed/30409838
  43. Vlavcheski F, O'Neill EJ, Gagacev F, Tsiani E. (2022). Effects of Berberine against Pancreatitis and Pancreatic Cancer. Molecules, 27(23). doi:10.3390/molecules27238630 https://www.ncbi.nlm.nih.gov/pubmed/36500723
  44. Wang D, Qin L, Jing C, et al. (2024). Biologically active isoquinoline alkaloids covering 2019-2022. Bioorg Chem, 145, 107252. doi:10.1016/j.bioorg.2024.107252 https://www.ncbi.nlm.nih.gov/pubmed/38437763
  45. Wang X, Zhang Y, Yang Y, Wu X, Fan H, Qiao Y. (2017). Identification of berberine as a direct thrombin inhibitor from traditional Chinese medicine through structural, functional and binding studies. Sci Rep, 7, 44040. doi:10.1038/srep44040 https://www.ncbi.nlm.nih.gov/pubmed/28276481
  46. Wang Y, Tong Q, Ma SR, et al. (2021). Oral berberine improves brain dopa/dopamine levels to ameliorateParkinson's disease by regulating gut microbiota. Signal Transduct Target Ther, 6(1), 77. doi:10.1038/s41392-020-00456-5 https://www.ncbi.nlm.nih.gov/pubmed/33623004
  47. Warowicka A, Nawrot R,Gozdzicka-Jozefiak A. (2020). Antiviral activity of berberine. Arch Virol, 165(9), 1935-1945. doi:10.1007/s00705-020-04706-3 https://www.ncbi.nlm.nih.gov/pubmed/32594322
  48. Weinberg JL. (2024). Managing High Potassium: A Guide for Patients and Practitioners. Rupa Health. Retrieved from https://www.rupahealth.com/post/managing-high-potassium-a-guide-for-patients-and-practitioners
  49. Williamson KM, Patterson JH, McQueen RH, Adams KF, Jr., Pieper JA. (1998). Effects of erythromycin or rifampin on losartan pharmacokinetics in healthy volunteers. Clin Pharmacol Ther, 63(3), 316-23. doi:10.1016/S0009-9236(98)90163-1 https://www.ncbi.nlm.nih.gov/pubmed/9542475
  50. Xie Y, Liu X, Zhou P. (2020). In vitro Antifungal Effects of Berberine Against Candida spp. In Planktonic and Biofilm Conditions. Drug Des Devel Ther, 14, 87-101. doi:10.2147/DDDT.S230857 https://www.ncbi.nlm.nih.gov/pubmed/32021094
  51. Yang L, Huang Y, Chen F, et al. (2023). Berberine attenuates depression-like behavior by modulating the hippocampal NLRP3 ubiquitination signaling pathway through Trim65. Int Immunopharmacol, 123, 110808. doi:10.1016/j.intimp.2023.110808 https://www.ncbi.nlm.nih.gov/pubmed/37595491
  52. Yoshinaga K. (1999). [Drug interactions and adverse effects of losartan potassium, an angiotensin II receptor antagonist]. Nihon Rinsho, 57(5), 1194-7.Β  https://www.ncbi.nlm.nih.gov/pubmed/10361455
  53. Yu M, Jin X, Liang C, et al. (2020). Berberine for diarrhea in children and adults: a systematic review and meta-analysis. Therap Adv Gastroenterol, 13, 1756284820961299. doi:10.1177/1756284820961299 https://www.ncbi.nlm.nih.gov/pubmed/33149763
  54. Zhang SW, Zhou J, Gober HJ, Leung WT,Wang L. (2021). Effect and mechanism of berberine against polycystic ovary syndrome. Biomed Pharmacother, 138, 111468. doi:10.1016/j.biopha.2021.111468 https://www.ncbi.nlm.nih.gov/pubmed/33740526
  55. Zhang X, Qiu F, Jiang J, Gao C, Tan Y. (2011). Intestinal absorption mechanisms of berberine, palmatine, jateorhizine, and coptisine: involvement of P-glycoprotein. Xenobiotica, 41(4), 290-6. doi:10.3109/00498254.2010.529180 https://www.ncbi.nlm.nih.gov/pubmed/21319959
  56. Zhang Y, Gu Y, Ren H, et al. (2020). Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study). Nat Commun, 11(1), 5015. doi:10.1038/s41467-020-18414-8 https://www.ncbi.nlm.nih.gov/pubmed/33024120
  57. Zhang Y, Guo L, Huang J, et al. (2019). Inhibitory Effect of Berberine on Broiler P-glycoprotein Expression and Function: In Situ and In Vitro Studies. Int J Mol Sci, 20(8). doi:10.3390/ijms20081966 https://www.ncbi.nlm.nih.gov/pubmed/31013627
  58. Zhou M, Deng Y, Liu M, et al. (2021). The pharmacological activity of berberine, a review for liver protection. Eur J Pharmacol, 890, 173655. doi:10.1016/j.ejphar.2020.173655 https://www.ncbi.nlm.nih.gov/pubmed/33068590
  59. Zhu C, Li K, Peng XX, et al. (2022). Berberine, a traditional Chinese drug repurposing: Its actions in inflammation-associated ulcerative colitis and cancer therapy. Front Immunol, 13, 1083788. doi:10.3389/fimmu.2022.1083788 https://www.ncbi.nlm.nih.gov/pubmed/36561763
Order from 30+ labs in 20 seconds (DUTCH, Mosaic, Genova & More!)
We make ordering quick and painless β€” and best of all, it's free for practitioners.

Latest Articles

View more on Cardiology
Subscribe to the magazine for expert-written articles straight to your inbox
Join the thousands of savvy readers who get root cause medicine articles written by doctors in their inbox every week!
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Trusted Source
Rupa Health
Medical Education Platform
Visit Source
Visit Source
American Cancer Society
Foundation for Cancer Research
Visit Source
Visit Source
National Library of Medicine
Government Authority
Visit Source
Visit Source
Journal of The American College of Radiology
Peer Reviewed Journal
Visit Source
Visit Source
National Cancer Institute
Government Authority
Visit Source
Visit Source
World Health Organization (WHO)
Government Authority
Visit Source
Visit Source
The Journal of Pediatrics
Peer Reviewed Journal
Visit Source
Visit Source
CDC
Government Authority
Visit Source
Visit Source
Office of Dietary Supplements
Government Authority
Visit Source
Visit Source
National Heart Lung and Blood Institute
Government Authority
Visit Source
Visit Source
National Institutes of Health
Government Authority
Visit Source
Visit Source
Clinical Infectious Diseases
Peer Reviewed Journal
Visit Source
Visit Source
Brain
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Rheumatology
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the National Cancer Institute (JNCI)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Cardiovascular Magnetic Resonance
Peer Reviewed Journal
Visit Source
Visit Source
Hepatology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Clinical Nutrition
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Bone and Joint Surgery
Peer Reviewed Journal
Visit Source
Visit Source
Kidney International
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Allergy and Clinical Immunology
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Surgery
Peer Reviewed Journal
Visit Source
Visit Source
Chest
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Neurology, Neurosurgery & Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Blood
Peer Reviewed Journal
Visit Source
Visit Source
Gastroenterology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Respiratory and Critical Care Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Diabetes Care
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of the American College of Cardiology (JACC)
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Clinical Oncology (JCO)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Clinical Investigation (JCI)
Peer Reviewed Journal
Visit Source
Visit Source
Circulation
Peer Reviewed Journal
Visit Source
Visit Source
JAMA Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
PLOS Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Nature Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The BMJ (British Medical Journal)
Peer Reviewed Journal
Visit Source
Visit Source
The Lancet
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the American Medical Association (JAMA)
Peer Reviewed Journal
Visit Source
Visit Source
Pubmed
Comprehensive biomedical database
Visit Source
Visit Source
Harvard
Educational/Medical Institution
Visit Source
Visit Source
Cleveland Clinic
Educational/Medical Institution
Visit Source
Visit Source
Mayo Clinic
Educational/Medical Institution
Visit Source
Visit Source
The New England Journal of Medicine (NEJM)
Peer Reviewed Journal
Visit Source
Visit Source
Johns Hopkins
Educational/Medical Institution
Visit Source
Visit Source

Hey Practitioners! On December 11th, join Dr. Terry Wahls in a free live class where she'll share her groundbreaking methods for managing MS and autoimmune patients. This live session will address your most pressing questions and will take a closer look at treatment options beyond the conventional standards of care. Register here.

Register Here